pubmed-article:7993831 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0042963 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0011777 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0025853 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0061863 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:7993831 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:7993831 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:7993831 | pubmed:dateCreated | 1995-1-13 | lld:pubmed |
pubmed-article:7993831 | pubmed:abstractText | Three anti-emetic treatment regimens were compared in 357 patients receiving cisplatin therapy (mean dose 81 mg/m2) in this double-blind randomized study. Regimens studied were i) granisetron 1 mg bd orally for 7 days (granisetron alone); ii) gran 1 mg bd orally for 7 days plus prophylactic dexamethasone (12 mg i.v.) on the first day only (gran/dex); iii) metoclopramide (3 mg/kg i.v. loading dose; 4 mg/kg i.v. infusion) plus dex (12 mg i.v.) on the first day followed by met 10 mg orally tds for a further 6 days (met/dex). | lld:pubmed |
pubmed-article:7993831 | pubmed:language | eng | lld:pubmed |
pubmed-article:7993831 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7993831 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7993831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7993831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7993831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7993831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7993831 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7993831 | pubmed:month | Sep | lld:pubmed |
pubmed-article:7993831 | pubmed:issn | 0923-7534 | lld:pubmed |
pubmed-article:7993831 | pubmed:author | pubmed-author:HeronJ FJF | lld:pubmed |
pubmed-article:7993831 | pubmed:author | pubmed-author:CunninghamJJ | lld:pubmed |
pubmed-article:7993831 | pubmed:author | pubmed-author:GoedhalsLL | lld:pubmed |
pubmed-article:7993831 | pubmed:author | pubmed-author:JordaanJ PJP | lld:pubmed |
pubmed-article:7993831 | pubmed:author | pubmed-author:CedarEE | lld:pubmed |
pubmed-article:7993831 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7993831 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:7993831 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7993831 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7993831 | pubmed:pagination | 579-4 | lld:pubmed |
pubmed-article:7993831 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:meshHeading | pubmed-meshheading:7993831-... | lld:pubmed |
pubmed-article:7993831 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7993831 | pubmed:articleTitle | Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group. | lld:pubmed |
pubmed-article:7993831 | pubmed:affiliation | Centre François Baclesse, Caen, France. | lld:pubmed |
pubmed-article:7993831 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7993831 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7993831 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:7993831 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7993831 | lld:pubmed |